News

On Vedanta

This stock has been sideways. It is lacking momentum on the upside. We have seen metals providing some sort of respite, but this stock has been lacking that momentum. In fact, below ₹440, we can see some sort of selling pressure increasing. I wouldn’t be surprised if the stock goes to levels of ₹400-405.

Natco Pharma on Wednesday, August 20, announced it has launched oral suspension tablets used in the treatment of pulmonary arterial hypertension (PAH).

Gopal Jain, a Senior Lawyer at the Supreme Court, believes the sweeping framework of the Online Gaming Bill, 2025, could weigh heavily on investor sentiment, jobs, and innovation. He stressed the need for deeper examination through consultation and debate before the legislation takes final shape. here

here

Vedanta Demerger Case

Aurobindo Pharma Ltd. on Wednesday, August 20, clarified that reports of a potential acquisition by the company are premature and should not be relied upon. here

Shares of NTPC Ltd. gained on Wednesday, August 20, as brokerage firm CLSA projected a 37% upside on the stock after its analyst meet. here

The BJP-led Central government is likely to introduce the Promotion and Regulation of Online Gaming Bill, 2025, in the Lok Sabha on Wednesday. The bill intends to prohibit the offering, operation, facilitation, advertisement, promotion, and participation in online money games via any computer resource, mobile device, or the internet, particularly where such activities take place over state borders or in foreign jurisdictions. here

Aditya Agarwala, Head-Research & Investments Invest4edu

Buy Marico for a target price of ₹765 with a stop loss of ₹730

Buy Tata Steel for a target price of ₹170 with a stop loss of ₹156

India’s stock market has had a tough year, but things could be looking up. Falling oil prices, some policy breathing space at home, and potential rate cuts may give investors reasons to be more optimistic, says Geoffrey Dennis, independent emerging markets commentator. here

#JustIn | #SC dismisses #VedantaGrp’s (#TalwandiSabo) plea seeking additional compensation, plea for compensation citing withdrawal of deemed export benefits.

SC has upheld APTEL order, held that Talwandi was never legitimately entitled to ‘deemed export’ benefits pic.twitter.com/VsRvyTwKmL

— CNBC-TV18 (@CNBCTV18Live) August 20, 2025

CLSA’s global chartist Laurence Balanco said that he expects the Nifty to revisit its all-time highs and possibly touch 26,300 by year-end, provided the 24,000 level holds. here

The government on Wednesday defended the proposed Online Gaming Bill, saying the legislation is designed to protect users while holding companies accountable. Sources told CNBC-TV18 that while the real-money gaming sector employs thousands, the “balance of convenience” lies with the crores of people adversely impacted by such games. here

US President Donald Trump has levied heavy tariffs on India as part of measures to put pressure on Russia to end the Ukraine conflict, according to the White House. White House Press Secretary Karoline Leavitt stated that Trump has put “tremendous public pressure to bring this war to a close” and wants to see the war end. here

Shares of Dynamic Cables Ltd., the manufacturer and supplier of cables and conductors, are locked in a 20% upper circuit on Wednesday, August 20. here

Aurobindo Pharma says

Market Watch: Dharmesh Shah, Vice President Head of Technical, ICICI Securities

Dharmesh Kant, Head-Research of Chola Securities

On Nazara Technologies

CNBC-TV18 Exclusive | Govt Sources Say

Natco Pharma announced it has launched oral suspension tablets used in the treatment of pulmonary arterial hypertension (PAH).NewsLive TVMarketPopular CategoriesCalculatorsTrending NowLet's Connect with CNBCTV 18Network 18 Group :©TV18 Broadcast Limited. All rights reserved.